Interferon induces thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in vivo

Clinical Cancer Research

Volumn 3, Issue 6, 1997, Pages 923-929

  Makower, Della ^a   Wadler, Scott ^a   Haynes, Hilda ^a   Schwartz, Edward L ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; ENDOTHELIAL CELL GROWTH FACTOR; FLUOROURACIL; HYDROXYUREA; INTERFERON BETA SERINE; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; THYMIDINE PHOSPHORYLASE;

ARTICLE; CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; GENE EXPRESSION; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BLOOD PLATELETS; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; COLONIC NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; ENZYME INDUCTION; FLUOROURACIL; HUMANS; HYDROXYUREA; INTERFERON ALFA-2A; INTERFERON ALFA-2B; INTERFERON-BETA; LEUKOCYTES, MONONUCLEAR; NEOPLASMS; RECOMBINANT PROTEINS; RNA, MESSENGER; THYMIDINE PHOSPHORYLASE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030993629     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Friedkin, M., and Roberts, D. The enzymatic synthesis of nucleosides. II. Thymidine and related pyrimidine nucleosides. J. Biol. Chem., 207: 245-256, 1954.
2. Krenitsky, T. A. Pentosyl transfer mechanisms of the mammalian nucleoside phosphorylases. J. Biol. Chem., 243: 2871-2875, 1968.
3. Iltzsch, M. H., el Kouni, M. H., and Cha, S. Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry, 24: 6799-6807, 1985.
4. Weckbecker, G. Biochemical pharmacology and analysis of fluoropyrimidines alone and in combination with modulators. Pharmacol. Ther., 50: 376-424, 1991.
5. Schwartz, E. L., Baptiste, N., Wadler, S., and Makower, D. Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil. J. Biol. Chem., 270: 19073-19077, 1995.
6. Elias, L., and Crissman, H. A. Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites. Cancer Res., 48: 4868-4873, 1988.
7. Wadler, S., Wersto, R., Weinberg, V., Thompson, D., and Schwartz, E. L. Interaction of 5-fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects. Cancer Res., 50: 5735-5739, 1990.
8. Schwartz, E. L., Hoffman, M., O'Connor, C. J., and Wadler, S. Stimulation of 5-fluorouracil metabolic activation by interferon-α in human colon carcinoma cells. Biochem. Biophys. Res. Commun., 182: 1232-1239, 1992.
9. Schwartz E. L., Baptiste, N., O'Connor, C. J., Wadler, S., and Otter, B. A. Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase. Cancer Res., 54: 1472-1478, 1994.
10. Moghaddam, A., and Bicknell, R. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry, 31: 12141-12146, 1992.
11. Furukawa, T., Yoshimura, A., Sumizawa, T., Haraguchi, M., Akiyama, S-I., Fukui, K., Ishizawa, M., and Yamada, Y. Angiogenic factor. Nature (Lond.), 356: 668, 1992.
12. Usuki, K., Saras, J., Waltenberger, J., Miyazono, K., Pierce, G., Thomason, A., and Heldin, C-H. Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem. Biophys. Res. Commun., 184: 1317-1323, 1992.
13. Zimmerman, M., and Seidenberg, J. Deoxyribosyl transfer. I. Thymidine phosphorylase and nucleoside deoxyribosyltransferase in normal and malignant tissues. J. Biol. Chem., 239: 2618-2621, 1964.
14. Pauly, J. L., Schuller, M. G., Zelcer, A. A., Kirss, T. A., Gore, S. S., and Germain, M. J. Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients: brief communication. J. Natl. Cancer Inst., 58: 1587-1590, 1977.
15. Pauly, J. L., Paolini, N. S., Ebarb, R. L., and Germain, M. J. Elevated thymidine phosphorylase activity in the plasma and ascites of tumor-bearing animals. Proc. Soc. Exp. Biol. Med., 157: 262-267, 1978.
16. Yoshimura, A., Kuwazuru, Y., Furukawa, T., Yoshida, H., Yamada, K., and Akiyama, S. Purification and tissue distribution of human thymidine phosphorylase: high expression in lymphocytes, reticulocytes and tumors. Biochim. Biophys. Acta, 1034: 107-113, 1990.
17. Peters, G. J., van Groeningen, C. J., Laurensse, E. J., and Pinedo, H. M. A comparison of 5-fluorouracil metabolism in human colorectal cancer and colon mucosa. Cancer (Phila.), 68: 1903-1909, 1991.
18. Luccioni, C., Beaumatin, J., Bardot, V., and Lefrancois, D. Pyrimidine nucleotide metabolism in human colon carcinomas: comparison of normal tissues, primary tumors and xenografts. Int. J. Cancer, 58: 517-522, 1994.
19. Takebayashi, Y., Akiyama, S., Akiba, S., Yamada, K., Miyadera, K., Sumizawa, T., Yamada, Y., Murata, F., and Aikou, T. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J. Natl. Cancer Inst., 88: 1110-1117, 1996.
20. Fox, S. B., Westwood, M., Moghaddam, A., Comley, M., Turley, H., Whitehouse, R. M., Bicknell, R., Gatter, K. C., and Harris, A. L. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br. J. Cancer, 73: 275-280, 1996.
21. Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W., and Heldin, C-H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature (Lond.), 338: 557-562, 1989.
22. Danhauser, L. L., Freimann, J. H., Gilchrist, T. L., Gutterman, J. U., Hunter, C. Y., Yeomans, A. C., and Markowitz, A. B. Phase I and plasma pharmacokinetic study of infusional fluorouracil combined with recombinant interferon α-2b in patients with advanced cancer. J. Clin. Oncol., 11: 751-761, 1993.
23. Singh, R. K., Gutman, M., Bucana, C. D., Sanchez, R., Llansa, N., and Fidler, I. J. Interferons α and β down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc. Natl. Acad. Sci. USA, 92: 4562-4566, 1995.
24. Ezekowitz, R. A. B., Mulliken, J. B., and Folkman, J. Interferon α-2a therapy for life-threatening hemangiomas of infancy. N. Engl. J. Med., 326: 1456-1463, 1992.
25. Fox, S. B., Moghaddam, A., Westwood, M., Turley, H., Bicknell, R., Gatter, K. C., and Harris, A. L. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J. Pathol., 176: 183-190, 1995.
26. Takahasi, Y., Bucana, C. D., Liu, W., Yoneda, J., Kitadai, Y., Cleary, K. R., and Ellis, L. M. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J. Natl. Cancer Inst., 88: 1146-1151, 1996.
27. Lewis, C. E., Leek, R., Harris, A. L., and McGee, J. O. Cytokine regulation of angiogenesis in breast cancer: role of tumor-associated macrophages. J. Leukocyte Biol., 57: 747-751, 1995.
28. Schwartz, E. L., Baptiste, N., Megati, S., Wadler, S., and Otter, B. A. 5-Ethoxy-2′-deoxyuridine, a novel thymidine phosphorylase substrate, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase. Cancer Res., 55: 3543-3540, 1995.
29. Friedman, R. L., Manly, S. P., McMahon, M., Kerr, I. M., and Stark, G. R. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell, 38: 745-755, 1984.
30. Schindler, C., and Darnell, J. E. Transcriptional responses to polypeptide ligands: the Jak-Stat pathway. Annu. Rev. Biochem., 64: 621-651, 1995.
31. Harris, B. E., Song, R., Soong, S. J., and Diasio, R. B. Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. Cancer Res., 50: 197-201, 1990.
32. Naguib, N. M., Soong, S-J., and el Kouni, M. H. Circadian rhythm of orotate phosphoribosyltransferase, pyrimidine nucleoside phosphorylase and dihydrouracil dehydrogenase in mouse liver. Biochem. Pharmacol., 45: 667-673, 1993.
33. Piper, A. A., Tattersall, M. H. N., and Fox, R. M. The activities of thymidine metabolising enzymes during the cell cycle of a human lymphocyte cell line LAZ-007 synchronised by centrifugal elutriation. Biochim. Biophys. Acta, 633: 400-409, 1980.
34. Washstein, W. L. Increased levels of thymidylate synthase in cells exposed to 5-fluorouracil. Mol. Pharmacol., 25: 171-177, 1984.
35. Chu, E., Koeller, D. M., Casey, J. L., Drake, J. C., Chabner, B. A., Elwood, P. C., Zinn, S., and Allegra, C. J. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc. Natl. Acad. Sci. USA, 88: 8977-8981, 1991.
36. Liberati, A. M., Garovani, P., and de Angelis, V. Double-blind randomised phase I study on the clinical tolerance and pharmacodynamics of natural and recombinant interferon-β given intravenously. J. Interferon Res., 12: 329-336, 1994.
37. Witt, P. L., Storer, B. E., Bryan, G. T., Brown, R. R., Flashner, M., Larocca, C. B., and Borden, E. C. Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-β. J. Immunother., 13: 191-200, 1993.
38. Kusari, J., and Sen, G. C. Transcriptional analyses of interferon-mducible mRNAs. Mol. Cell. Biol., 7: 528-531, 1987.
39. Lew, D. J., Decker, T., and Darnell, J. E. α interferon and γ interferon stimulate transcription of a single gene through different signal transduction pathways. Mol. Cell. Biol., 9: 5404-5411, 1989.
40. Shaw, T., Smillie, R. H., Miller, A. E., and MacPhee, D. G. The role of blood platelets in nucleoside metabolism: assay, cellular location and significance of thymidine phosphorylase in human blood. Mutat. Res., 200: 99-116, 1988.